Regulatory Consulting Services
Scientific Insight for Complex Regulatory Decisions
Scientific innovation often brings complex regulatory questions. An unexpected finding, an incomplete evidence package, or an emerging technology can create uncertainty about what the data mean and what should happen next. Through careful examination of the evidence, Roper Toxicology Consulting Limited (Roper TCL) helps organisations develop a scientifically sound path towards answering these questions.
Navigate Complexity with Clarity
Scientific innovation often brings complex regulatory questions. An unexpected finding, an incomplete evidence package, or an emerging technology can create uncertainty about what the data mean and what should happen next. Through careful examination of the evidence, Roper Toxicology Consulting Limited (Roper TCL) helps organisations develop a scientifically sound path towards answering these questions.
Regulatory Strategy Grounded in Scientific Evidence
Effective Regulatory Support
Effective regulatory support requires more than familiarity with a guideline or submission process. It requires a clear understanding of the scientific question, the quality and relevance of the available evidence, and how that evidence may be evaluated by regulators and other stakeholders. Roper TCL helps clients build a transparent scientific rationale for their decisions. This may involve reviewing historical data, exploring alternative explanations for a finding, assessing species or human relevance, identifying critical evidence gaps and determining whether a method is fit for its intended purpose.
The objective is not to generate more data simply for the sake of it. It is to assemble the right evidence to answer the question as clearly and efficiently as possible.
Established Methods, NAMs, and Emerging Technologies
As toxicology evolves, organisations must decide how established methods, New Approach Methodologies (NAMs), and human-relevant models can be used appropriately within product development and safety assessment programs. Roper TCL evaluates these approaches in relation to biological relevance, reliability, limitations, regulatory context, and intended context of use.
A Collaborative, Director, Led Approach
No two projects present the same combination of scientific, regulatory, and organisational factors. Clive works directly with scientific, regulatory, legal, and leadership teams to understand the issues, evaluate options, and communicate clear recommendations. Support may range from a focused independent review to continued involvement through study planning, partner or CRO coordination, data interpretation, report development, and regulatory communication.
How Roper TCL Can Support Your Organization
-
Toxicological risk assessment and product safety evaluation
-
Study strategy, experimental design, and protocol review
-
Interpretation of complex, conflicting, or unexpected findings
-
Data review, evidence gap assessment, and weight-of-evidence evaluation
-
Scientific strategy and content for regulatory questions and submissions
-
Evaluation of established and emerging models, methods, and technologies
-
Scientific due diligence for technologies, partnerships, and investments
-
Independent scientific review, technical writing, and expert advice
Case Study: Clarifying Ambiguous Toxicology Findings
The Challenge
A client needed to understand the link between rat in vivo findings and what may happen in humans and to determine whether the observed rat responses represented biological adaptation or an adverse toxicological effect.
Roper TCL's Approach
Roper TCL developed a targeted strategy using appropriate human and animal liver and kidney models in parallel. Comparing responses across species and organ systems provided a clear basis for assessing the biological significance and human relevance of the original findings.
The Value
The resulting evidence supported the interpretation that the findings did not indicate an adverse effect in humans under the conditions evaluated, but the changes were observed in the rat in vitro confirming mechanistically that the changes were adaptational in the rat in vivo. This gave the client a stronger scientific basis for addressing regulatory questions without performing additional animal studies. The data were submitted to the relevant regulatory agency for consideration.
This case illustrates the value of selecting models around the scientific context of use, using targeted, comparative, and human-relevant evidence to clarify uncertainty and support a more informed regulatory response.
Facing a Difficult Regulatory Challenge?
Whether you are interpreting a complex toxicology finding, evaluating an evidence gap, developing a testing strategy, or preparing for an important regulatory discussion, Roper TCL can help you move forward with greater clarity and confidence.
Discuss Your Requirements →